Search research articles
Contact Us
Filters
Showing results (571-580 of 667) with videos related to
Page
of 67
Sort By:
Neurology
|
January 28, 1999
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia
L J Launer, K Andersen, M E Dewey, et al.
Melanoma Research
|
September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
Shalin Shah, Jason J Luke, Heather A Jacene, et al.
Cancer Immunology Research
|
April 12, 2017
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma
Daniel Y Wang, Zeynep Eroglu, Alpaslan Ozgun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 2022
Retrospective Review of Outcomes After Radiation Therapy for Oligoprogressive Disease on Immune Checkpoint Blockade
Umair Mahmood, Mai Anh Huynh, Joseph H Killoran, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
August 27, 2017
Abstinence-Only-Until-Marriage: An Updated Review of U.S. Policies and Programs and Their Impact
John S Santelli, Leslie M Kantor, Stephanie A Grilo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2018
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
A R Hansen, C Massard, P A Ott, et al.
Cancer Immunology Research
|
November 9, 2019
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
Anna Pavlick, Ana B Blazquez, Marcia Meseck, et al.
Gynecologic Oncology
|
April 1, 2022
Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study
Ronnie Shapira-Frommer, Linda Mileshkin, Ludmila Manzyuk, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2018
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
Luke R G Pike, Andrew Bang, Brandon A Mahal, et al.
Molecular Cancer Research : MCR
|
October 17, 2023
SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death
Sheera R Rosenbaum, Signe Caksa, Casey D Stefanski, et al.
Page
of 67
Search research articles
Search
Showing results (571-580 of 667) with videos related to
Sort By:
Page
of 67
Neurology
|
January 28, 1999
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia
L J Launer, K Andersen, M E Dewey, et al.
Melanoma Research
|
September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
Shalin Shah, Jason J Luke, Heather A Jacene, et al.
Cancer Immunology Research
|
April 12, 2017
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma
Daniel Y Wang, Zeynep Eroglu, Alpaslan Ozgun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 2022
Retrospective Review of Outcomes After Radiation Therapy for Oligoprogressive Disease on Immune Checkpoint Blockade
Umair Mahmood, Mai Anh Huynh, Joseph H Killoran, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
August 27, 2017
Abstinence-Only-Until-Marriage: An Updated Review of U.S. Policies and Programs and Their Impact
John S Santelli, Leslie M Kantor, Stephanie A Grilo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2018
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
A R Hansen, C Massard, P A Ott, et al.
Cancer Immunology Research
|
November 9, 2019
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
Anna Pavlick, Ana B Blazquez, Marcia Meseck, et al.
Gynecologic Oncology
|
April 1, 2022
Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study
Ronnie Shapira-Frommer, Linda Mileshkin, Ludmila Manzyuk, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2018
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
Luke R G Pike, Andrew Bang, Brandon A Mahal, et al.
Molecular Cancer Research : MCR
|
October 17, 2023
SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death
Sheera R Rosenbaum, Signe Caksa, Casey D Stefanski, et al.
Page
of 67